Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 11,190 | 827 | -3,040 | -6,758 | 174 |
| Depreciation Amortization | 710 | 1,006 | 1,095 | 1,085 | 911 |
| Income taxes - deferred | -11,181 | N/A | N/A | N/A | N/A |
| Accounts receivable | -933 | -223 | 1,033 | -548 | 351 |
| Accounts payable and accrued liabilities | 442 | -497 | -109 | 84 | 241 |
| Other Working Capital | 22,493 | 179 | 2,267 | 1,081 | -3,318 |
| Other Operating Activity | 1,103 | 720 | -914 | 742 | -243 |
| Operating Cash Flow | $23,825 | $2,012 | $332 | $-4,314 | $-1,883 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 818 | 1,741 | 1,689 | 6,045 | 3,674 |
| PPE Investments | -474 | -256 | -89 | -908 | -505 |
| Other Investing Activity | 0 | 0 | 5 | -24 | 0 |
| Investing Cash Flow | $344 | $1,485 | $1,605 | $5,113 | $3,169 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 578 | 93 | N/A | N/A | 540 |
| Financing Cash Flow | $578 | $93 | $N/A | $N/A | $540 |
| Beginning Cash Position | 14,592 | 11,002 | 9,065 | 8,266 | 6,441 |
| End Cash Position | 39,339 | 14,592 | 11,002 | 9,065 | 8,266 |
| Net Cash Flow | $24,747 | $3,590 | $1,937 | $799 | $1,825 |
| Free Cash Flow | |||||
| Operating Cash Flow | 23,825 | 2,012 | 332 | -4,314 | -1,883 |
| Capital Expenditure | -474 | -256 | -89 | -908 | -505 |
| Free Cash Flow | 23,351 | 1,756 | 243 | -5,222 | -2,389 |